Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1068/week)
    • Manufacturing(539/week)
    • Technology(986/week)
    • Energy(405/week)
    • Other Manufacturing(332/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Autosomal dominant polycystic kidney disease

Aug 13, 2020
Regulus Therapeutics Reports Second Quarter 2020 Financial Results and Recent Updates
May 14, 2020
Regulus Therapeutics Reports First Quarter 2020 Financial Results and Recent Updates
Apr 30, 2020
US Societal Economic Burden of an Inherited Kidney Disease Estimated at $7-10 Billion
Mar 12, 2020
Regulus Reports Fourth Quarter and Year-End 2019 Financial Results and Recent Updates
Oct 16, 2019
Regulus Therapeutics Presents Preclinical Data Identifying RGLS4326 as a Potential Disease-Modifying Treatment for Autosomal Dominant Polycystic Kidney Disease at OTS Annual Meeting
Oct 15, 2019
Study Demonstrates Continuing Education Improved Health Care Providers' Knowledge of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Sep 12, 2019
Regulus Therapeutics Announces Publication in Nature Communications Identifying RGLS4326 as a Potential Promising Treatment for ADPKD
Aug 08, 2019
Regulus Therapeutics Reports Second Quarter 2019 Financial Results and Recent Updates
Jul 23, 2019
Regulus Therapeutics Announces RGLS4326 Program Update
May 09, 2019
Regulus Therapeutics Reports First Quarter 2019 Financial Results and Recent Updates
May 07, 2019
Regulus Therapeutics Announces Closing of First Tranche of $41.8 Million Private Placement of Equity
May 06, 2019
Regulus Therapeutics Announces Restructuring of Term Loan
Mar 15, 2019
Regulus Announces Transition of Research Leadership
Jan 31, 2019
2018 Pipeline Review on Renal Diseases - Which Companies are the Most Active within Each Pipeline
Jan 08, 2019
Slone Partners, Where People Are Our Science®, Places Frank Czerwiec M.D., Ph.D. as Chief Medical Officer at Goldfinch Bio
Nov 08, 2018
Regulus Reports Third Quarter 2018 Financial Results and Recent Updates
Oct 26, 2018
Research in Polycystic Kidney Disease Takes an Important Step Forward
Oct 22, 2018
Regulus to Present Preclinical Data Supporting RGLS4326 as a Novel Therapeutic in Development for Autosomal Dominant Polycystic Kidney Disease at ASN's Kidney Week 2018
Sep 26, 2018
Regulus Provides Pipeline Updates
May 10, 2018
PANTHERx® Specialty Pharmacy Selected by Otsuka to Distribute JYNARQUE
  •  
  • Page 1
  • ››

Latest News

Jun 24, 2025

Operio Group Names Declan McLaughlin as New CEO

Jun 24, 2025

Global Risk Consultants Corp. and VDE Americas Announce Strategic Partnership to Enhance Catastrophic Hail...

Jun 24, 2025

Photonic Inc. Appoints Top Tech Leaders to Accelerate Quantum Innovation and Growth

Jun 24, 2025

U.S. Pole Company Changes Name to U.S. Outdoor Lighting™: Same Legacy. New Name. Reengineered for Today’s...

Jun 24, 2025

American Home Shield Celebrates American Independence with 50% Off Home Warranties

Jun 24, 2025

Rootstock Software Named an ERP Leader for Fourth Consecutive Year in Nucleus Research’s 2025 Value Matrix

Jun 24, 2025

Waites Launches Universal Adapter Suite for Enhanced Sensor Interoperability

Jun 24, 2025

2024 Interface Impact Report Highlights Continued Climate Progress, Purpose-Driven Culture Investments

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia